一项探索人们对国际疾病分类（第 11 版）观点的定性研究方案；利用生活体验改善英国国民保健制度英格兰地区的心理健康诊断：INCLUDE 研究。
Protocol for a qualitative study exploring perspectives on the INternational CLassification of Diseases (11th revision); Using lived experience to improve mental health Diagnosis in NHS England: INCLUDE study.
机构信息
Department of Research and Development, Norfolk and Suffolk NHS Foundation Trust, Hellesdon Hospital, Norwich, UK.
Department of Clinical Psychology, Norwich Medical School, University of East Anglia, Norwich, UK.
出版信息
BMJ Open. 2017 Sep 3;7(9):e018399. doi: 10.1136/bmjopen-2017-018399.
INTRODUCTION
Developed in dialogue with WHO, this research aims to incorporate lived experience and views in the refinement of the International Classification of Diseases Mental and Behavioural Disorders 11th Revision (ICD-11). The validity and clinical utility of psychiatric diagnostic systems has been questioned by both service users and clinicians, as not all aspects reflect their lived experience or are user friendly. This is critical as evidence suggests that diagnosis can impact service user experience, identity, service use and outcomes. Feedback and recommendations from service users and clinicians should help minimise the potential for unintended negative consequences and improve the accuracy, validity and clinical utility of the ICD-11.
METHODS AND ANALYSIS
The name INCLUDE reflects the value of expertise by experience as all aspects of the proposed study are co-produced. Feedback on the planned criteria for the ICD-11 will be sought through focus groups with service users and clinicians. The data from these groups will be coded and inductively analysed using a thematic analysis approach. Findings from this will be used to form the basis of co-produced recommendations for the ICD-11. Two service user focus groups will be conducted for each of these diagnoses: Personality Disorder, Bipolar I Disorder, Schizophrenia, Depressive Disorder and Generalised Anxiety Disorder. There will be four focus groups with clinicians (psychiatrists, general practitioners and clinical psychologists).
ETHICS AND DISSEMINATION
This study has received ethical approval from the Coventry and Warwickshire HRA Research Ethics Committee (16/WM/0479). The output for the project will be recommendations that reflect the views and experiences of experts by experience (service users and clinicians). The findings will be disseminated via conferences and peer-reviewed publications. As the ICD is an international tool, the aim is for the methodology to be internationally disseminated for replication by other groups.
TRIAL REGISTRATION NUMBER
ClinicalTrials.gov: NCT03131505.
简介
本研究是与世界卫生组织合作开展的，旨在将生活经验和观点纳入《国际疾病分类精神与行为障碍第 11 版》（ICD-11）的修订工作中。服务使用者和临床医生都对精神科诊断系统的有效性和临床实用性提出了质疑，因为并非所有方面都能反映他们的生活经验或方便使用者。这一点至关重要，因为有证据表明，诊断可能会影响服务使用者的体验、身份、服务使用和结果。服务使用者和临床医生的反馈和建议应有助于尽量减少潜在的负面影响，并提高 ICD-11 的准确性、有效性和临床实用性。
方法和分析
“INCLUDE”这个名称反映了经验专业知识的价值，因为研究的所有方面都是共同制定的。将通过与服务使用者和临床医生举行焦点小组会议，征求对 ICD-11 拟议标准的反馈意见。这些小组的数据将使用主题分析方法进行编码和归纳分析。从这些分析中得出的结果将用于为 ICD-11 共同制定建议。将针对这些诊断中的每一种进行两次服务使用者焦点小组：人格障碍、双相 I 型障碍、精神分裂症、抑郁症和广泛性焦虑症。将有四个临床医生焦点小组（精神科医生、全科医生和临床心理学家）。
伦理和传播
本研究已获得考文垂和沃里克郡 HRA 研究伦理委员会的伦理批准（16/WM/0479）。该项目的产出将是反映经验专家（服务使用者和临床医生）观点和经验的建议。研究结果将通过会议和同行评审出版物传播。由于 ICD 是一种国际工具，因此目标是在国际上传播该方法，以便其他团体复制。
试验注册编号
ClinicalTrials.gov：NCT03131505。
Zotero 插件